Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315393 · ClinicalTrials.gov registry record
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
A clinical trial of Microscopic Polyangiitis and Granulomatosis With Polyangiitis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 1,046
- Enrollment target
- 8
- Study locations
NCT00315393: Completed study of Microscopic Polyangiitis and Granulomatosis With Polyangiitis, sponsored by University of Pennsylvania.
NCT00315393 is a study of Microscopic Polyangiitis and Granulomatosis With Polyangiitis that has completed, run by University of Pennsylvania. The registered enrollment target is 1,046 participants, above the 679-participant average among 4 other Microscopic Polyangiitis trials with a reported enrollment target (54% higher). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315393, a study of Microscopic Polyangiitis and Granulomatosis With Polyangiitis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 1,046 participants
- Enrollment target
- 8
- Study locations
Study Summary
Granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA) are two rare immune system disorders that cause the inflammation of blood vessels, or vasculitis. In order to properly treat these diseases, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with GPA or MPA.
Conditions Studied
Study Locations (8)
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Ontario
- St. Joseph's Healthcare - Hamilton
- Mount Sinai Hospital - Toronto
Massachusetts
- Boston University School of Medicine - Boston
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic Foundation - Cleveland
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,046 participants |
| Start Date | 2006-04 |
| Est. Completion | 2019-12 |
What the finished NCT00315393 record still lists
NCT00315393 is an observational study that tracks outcomes without assigning an intervention. Its 1,046 participants enrollment target places it among the larger protocols in the corpus, above the 679-participant average among 4 other Microscopic Polyangiitis trials with a reported enrollment target (54% higher).
The record links to 3 conditions, with Microscopic Polyangiitis appearing as the primary indexed condition, and to 0 interventions.
NCT00315393 lists 8 locations in 6 states (Pennsylvania, Ontario, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT00315393 about?
NCT00315393 is a clinical study titled "Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis". Granulomatosis with polyangiitis (Wegener's) (GPA) and microscopic polyangiitis (MPA) are two rare immune system disorders that cause the inflammation of blood vessels, or vasculitis. In order to properly treat these diseases, it is critical that the level of disease activity can be determined over ...
What is the current status of trial NCT00315393?
This trial is currently completed. The enrollment target is 1,046 participants. The study started on 2006-04. Estimated completion is 2019-12.
What conditions does trial NCT00315393 study?
This clinical trial studies the following conditions: Microscopic Polyangiitis, Granulomatosis With Polyangiitis, Wegener's.
Who is sponsoring clinical trial NCT00315393?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00315393 being conducted?
This trial has 8 study locations across Massachusetts, Minnesota, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Microscopic Polyangiitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06717347 · 1,046 participants · Phase 3
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- NCT04505618 · 1,050 participants · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
- NCT04511806 · 1,050 participants
Childhood Cancer Predisposition Study (CCPS)
- NCT05028972 · 1,050 participants · NA
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia